mifepristone has been researched along with Peritoneal Carcinomatosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, J; Jia, L; Li, T; Liu, J; Liu, W; Wang, J; Zheng, N | 1 |
Brady, WE; Hoffman, JS; Mannel, RS; Rocereto, TF; Rotmensch, J; Shahin, MS; Small, L | 1 |
Copel, L; Halevy, A; Halpern, Z; Samuk, I; Sandbank, J; Ziv, Y | 1 |
1 trial(s) available for mifepristone and Peritoneal Carcinomatosis
Article | Year |
---|---|
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Fallopian Tube Neoplasms; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Mifepristone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms | 2010 |
2 other study(ies) available for mifepristone and Peritoneal Carcinomatosis
Article | Year |
---|---|
Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Topics: Abortifacient Agents; Animals; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Chemoprevention; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Receptors, CXCR4; Signal Transduction | 2017 |
Mifepristone (RU486), a pure antiprogesterone drug, in combination with vinblastine for the treatment of progesterone receptor-positive desmoid tumor.
Topics: Adenomatous Polyposis Coli; Adult; Anastomosis, Surgical; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Fibromatosis, Aggressive; Humans; Imaging, Three-Dimensional; Male; Mifepristone; Peritoneal Neoplasms; Proctocolectomy, Restorative; Receptors, Progesterone; Tomography, X-Ray Computed; Vinblastine | 2010 |